Acurx Pharmaceuticals, Inc. (ACXP)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Feb. 9, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Acurx Pharmaceuticals, Inc. that it will not review their registration statement filed on February 2, 2026. The letter emphasizes that the responsibili… | Read Filing EDGAR |
| Feb. 9, 2026 | CORRESP | Neutral/Informational | Moderate | Acurx Pharmaceuticals, Inc. has submitted a request for acceleration of the effective date of its Registration Statement on Form S-1, seeking to have it become effective on Februa… | Read Filing EDGAR |
| Jan. 2, 2026 | CORRESP | Neutral/Informational | Moderate | Acurx Pharmaceuticals, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-3, originally filed on July 9, … | Read Filing EDGAR |
| Jul. 21, 2025 | CORRESP | Neutral/Informational | Moderate | Acurx Pharmaceuticals, Inc. has submitted a request for acceleration of the effective date of its Registration Statement on Form S-1, seeking to have it become effective on July 2… | Read Filing EDGAR |
| Jul. 21, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has formally notified Acurx Pharmaceuticals, Inc. that it will not review their registration statement filed on July 15, 2025. The letter emphasizes the company's responsi… | Read Filing EDGAR |
| Jul. 14, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Acurx Pharmaceuticals, Inc. that it will not review their registration statement filed on July 9, 2025. The letter emphasizes that the responsibility f… | Read Filing EDGAR |